RT @EricTopol: New @Nature In-depth characterization of the BA.2 vs BA.1 variants from patient sera immune response and experimental model…
RT @RyutaUraki: Excited to share our work on the characterization and antiviral susceptibility of Omicron BA.2 variants in rodent models @n…
RT @RyutaUraki: Excited to share our work on the characterization and antiviral susceptibility of Omicron BA.2 variants in rodent models @n…
RT @Nature: Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2 - Nature https://t.co/x29rD1dCQE
Excited to share our work on the characterization and antiviral susceptibility of Omicron BA.2 variants in rodent models @nature https://t.co/yfSowTVokc This was really great teamwork, and I thank all the collaborators!#omicronBA2 #antivirals #pathogenici
RT @EricTopol: New @Nature In-depth characterization of the BA.2 vs BA.1 variants from patient sera immune response and experimental model…
RT @EricTopol: New @Nature In-depth characterization of the BA.2 vs BA.1 variants from patient sera immune response and experimental model…
RT @Nature: Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2 - Nature https://t.co/x29rD1dCQE
RT @EricTopol: New @Nature In-depth characterization of the BA.2 vs BA.1 variants from patient sera immune response and experimental model…
BA.2 and BA.1 are less pathogenicity compared to early SARS-CoV-2 strains in vivo.
RT @EricTopol: New @Nature In-depth characterization of the BA.2 vs BA.1 variants from patient sera immune response and experimental model…
RT @EricTopol: New @Nature In-depth characterization of the BA.2 vs BA.1 variants from patient sera immune response and experimental model…
Omicron is less pathogenic and MA still work against it. https://t.co/K9DZZvuns0
In mice BA.2 & BA.1 had similar infectivity and pathogenicity, and were less pathogenic compared to early SC2 strains. Abs of convalescent plasma & vaccine recipients were significantly reduced against BA.2 compared to ancestral and Delta variant s
RT @Nature: Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2 - Nature https://t.co/x29rD1dCQE
الفكرة ورب الكعبة إحنا كبني آدمين مش ملاحقينه والله... العيال لسه بتفهم BA. 2 ده بيقول إيه... يقوم هو داخل بالتالت والرابع ولا أكن السيتي بيلعب مع ايفرتون
RT @Nature: Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2 - Nature https://t.co/x29rD1dCQE
"findings suggest that the replication and pathogenicity of BA.2 is comparable to that of BA.1 in rodents and that several therapeutic monoclonal antibodies and antiviral compounds are effective against Omicron/BA.2 variants." https://t.co/0flWPU1CMP
RT @Nature: Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2 - Nature https://t.co/x29rD1dCQE
RT @Nature: Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2 - Nature https://t.co/x29rD1dCQE
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2 - Nature https://t.co/x29rD1dCQE
RT @EricTopol: New @Nature In-depth characterization of the BA.2 vs BA.1 variants from patient sera immune response and experimental model…
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2: replication & pathogenicity of BA.2 is comparable to BA.1 & that several therapeutic monoclonal antibodies and antiviral compounds are effective against Omicron/BA.2 variant
RT @EricTopol: New @Nature In-depth characterization of the BA.2 vs BA.1 variants from patient sera immune response and experimental model…
RT @thelonevirologi: Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2 https://t.co/ASZseoQQ8K
RT @EricTopol: New @Nature In-depth characterization of the BA.2 vs BA.1 variants from patient sera immune response and experimental model…
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2 https://t.co/ASZseoQQ8K
RT @EricTopol: New @Nature In-depth characterization of the BA.2 vs BA.1 variants from patient sera immune response and experimental model…
RT @EricTopol: New @Nature In-depth characterization of the BA.2 vs BA.1 variants from patient sera immune response and experimental model…
RT @EricTopol: New @Nature In-depth characterization of the BA.2 vs BA.1 variants from patient sera immune response and experimental model…
RT @EricTopol: New @Nature In-depth characterization of the BA.2 vs BA.1 variants from patient sera immune response and experimental model…
RT @EricTopol: New @Nature In-depth characterization of the BA.2 vs BA.1 variants from patient sera immune response and experimental model…
RT @EricTopol: New @Nature In-depth characterization of the BA.2 vs BA.1 variants from patient sera immune response and experimental model…
RT @EricTopol: New @Nature In-depth characterization of the BA.2 vs BA.1 variants from patient sera immune response and experimental model…
RT @EricTopol: New @Nature In-depth characterization of the BA.2 vs BA.1 variants from patient sera immune response and experimental model…
RT @EricTopol: New @Nature In-depth characterization of the BA.2 vs BA.1 variants from patient sera immune response and experimental model…
New @Nature In-depth characterization of the BA.2 vs BA.1 variants from patient sera immune response and experimental model supports their similarities https://t.co/TlNQw9qySJ https://t.co/xV3YooGmEK
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2 https://t.co/zQG6wC6HVi #science
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2 https://t.co/QcyyYJlGg5
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2: Nature, Published online: 16 May 2022; doi:10.1038/s41586-022-04856-1Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2 https://t.co/0FUoCfWVYD